Members

Founder Members

We are grateful to our four Founder Members, organisations with the deepest level of commitment to the CBA vision, mission and principles. Each Founder Member made a substantial unrestricted financial contribution.

Our four Founder Members are Lombard Odier, AstraZeneca, LVMH and Eranda Rothschild Foundation.

Lombard Odier is a global wealth and asset manager with a strong focus on sustainable investing. For over 225 years and through more than 40 financial crises, the Group has aligned itself with the long-term interests of private and institutional clients. It has a strong balance sheet with a CET1 ratio of 32% and a Fitch rating of AA-, the highest possible rating for a bank of its size.

Structured as an independent partnership, Lombard Odier is solely owned by its Managing Partners. This governance model allows the Bank to remain completely client-focused and innovative at the highest level in the organisation.

Lombard Odier is an investment house that provides a comprehensive offering of discretionary and advisory portfolio management, wealth services and custody. Asset management services are offered through Lombard Odier Investment Managers (LOIM). The Group has created cutting-edge banking technology, which is also leveraged by other Swiss and European-based private banks and financial institutions.

The Group had total client assets of CHF 296 billion at 31 December 2023. Headquartered in Geneva since 1796, at end-December the Group had 26 offices in 19 jurisdictions and employed 2,900 people.

A new economic paradigm is beginning to emerge, as the financial community wakes up to the essential role that nature will play in tackling the climate challenge. Lombard Odier is delighted to be a Founding Member of the Circular Bioeconomy Alliance, leveraging our expertise in attracting investors to the opportunity offered by Nature-based solutions, including the protection, restoration and sustainable management of our land systems. By unlocking and accelerating investment into nature at scale and working with like-minded partners within the Alliance, we look forward to supporting efforts to boost biodiversity and secure regenerative value chains – the very basis of a nature-positive economy.

Hubert Keller

Senior Managing Partner at Lombard Odier

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca’s innovative medicines are sold in more than 125 countries and used by millions of patients worldwide.

AstraZeneca is committed to operating sustainably, in a way that recognises the interconnection between business growth, the needs of society and the limitations of our planet. AZ Forest is AstraZeneca’s global initiative to plant and maintain 200 million trees across six continents by 2030, in partnership with planting experts, local communities and governments to deliver natural forest restoration and agroforestry.

The Circular Bioeconomy Alliance is a unique organisation, whose support for sustainable and resilient landscape generation is building ecological and community resilience around the world. As founding members of the CBA Charity, we are delighted to be deepening our collaboration, and continuing to support community-led reforestation and circular business models. Our partnership with the CBA on AZ Forest projects in Ghana and Rwanda demonstrates how effective public-private collaboration can drive sustainable impact at scale.

Liz Chatwin

VP Sustainability and SHE, AstraZeneca

The ERANDA Rothschild Foundation is a UK-registered grant making charity established in 1967. We award revenue grants to registered charities working in the fields of education, medical research and the arts, with an emphasis on the following areas:

  • The Arts – the Foundation supports the education and outreach work of arts charities.
  • Education – the Foundation considers applications from universities and other charities to support young professionals in fields including medicine, science and business. It supports disadvantaged young people and apprenticeships.
  • Health, Welfare and Medical Research – the Foundation supports original research and the continuation of existing research. Social welfare is also considered under the medical theme.

Whilst these are our priority areas we welcome applications from charitable organisations focusing on other areas that the Trustees can determine to support. We support global causes but emphasise those based in the UK and work with charities which are both large and small. 

The ERANDA Rothschild Foundation is delighted to be a founding member of the Circular Bioeconomy Alliance. This work at the intersection of science, preservation and community greatly aligns with other causes supported by the Foundation, and we believe that collaborating with the CBA will lead to positive change for people and planet. The concept of a circular bioeconomy presents a valuable framework for “using renewable natural capital to transform and manage our land, food, health and industrial systems as well as our cities”, which the CBA facilitates for the future of our economy.

Elena Harris

Executive Director, The ERANDA Rothschild Foundation